Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17253705 | Medicament Delivery Device | December 2020 | July 2023 | Allow | 31 | 0 | 0 | No | No |
| 17253073 | NEEDLE UNIT WITH BIOSTATIC CHAMBER | December 2020 | May 2024 | Abandon | 41 | 2 | 0 | No | No |
| 17097582 | HEMOSTASIS VALVE FOR SHEATH ASSEMBLY | November 2020 | August 2024 | Allow | 45 | 3 | 1 | No | No |
| 17054654 | AN INTRAVENOUS CATHETER DEVICE | November 2020 | January 2024 | Allow | 38 | 3 | 0 | No | No |
| 17085562 | DRUG INFUSION PORT | October 2020 | November 2023 | Allow | 37 | 2 | 1 | Yes | No |
| 17085360 | IMPLANTABLE MEDICAL DEVICE FOR DELIVERY OF PHARMACOLOGICAL AGENTS TO THE DEEP BRAIN STRUCTURES | October 2020 | February 2024 | Allow | 39 | 3 | 0 | Yes | No |
| 17037181 | DRUG SOLUTION ADMINISTRATION DEVICE AND CONTROL METHOD FOR DRUG SOLUTION ADMINISTRATION DEVICE | September 2020 | January 2025 | Abandon | 52 | 3 | 0 | Yes | No |
| 17043244 | METHOD OF REMOVAL OF GAS FROM RESERVOIR | September 2020 | December 2024 | Abandon | 50 | 2 | 0 | No | No |
| 17027773 | ILLUMINATING GUIDEWIRE WITH SLIP COUPLING BETWEEN SEGMENTS | September 2020 | April 2025 | Abandon | 55 | 5 | 1 | Yes | No |
| 17017339 | TECHNIQUE AND METHOD TO LOCALLY DELIVER OBJECTS INTO BONE | September 2020 | November 2023 | Abandon | 38 | 0 | 1 | No | No |
| 16969946 | Medical Injection Device for Supporting a Medical Container Filled With a Pharmaceutical Composition | August 2020 | March 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 16968767 | MEDICAL DEVICE FOR THE DELIVERY OF THERAPEUTIC FORMULATIONS AND METHODS OF USE THEREOF | August 2020 | March 2024 | Abandon | 43 | 1 | 0 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner FARRELL, KATHLEEN PAIGE works in Art Unit 3783 and has examined 12 patent applications in our dataset. With an allowance rate of 50.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.
Examiner FARRELL, KATHLEEN PAIGE's allowance rate of 50.0% places them in the 14% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by FARRELL, KATHLEEN PAIGE receive 2.08 office actions before reaching final disposition. This places the examiner in the 51% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by FARRELL, KATHLEEN PAIGE is 41 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +17.1% benefit to allowance rate for applications examined by FARRELL, KATHLEEN PAIGE. This interview benefit is in the 57% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 5% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.